Abstract
The growth hormone (GH) and prolactin (PRL) responses to metoclopramide (MCP) were compared to those with arginine and insulin-induced hypoglycemia in 8 children. While a significant rise in GH release after stimulation with arginine and insulin occurred in all subjects (P < 0.05), no significant increase after MCP ingestion was observed. Metoclopramide, a dopamine antagonist, stimulated PRL release in all children, while arginine and insulin-induced hypoglycemia stimulation tests showed variable PRL responses. A statistically significant increase in cortisol secretion 5 h following MCP was observed (P < 0.05), but the plasma concentration at this time was still within the normal range. Metoclopramide stimulation is not a suitable test for GH deficiency in children.